Suchergebnisse - "Cegielski, J Peter"

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline von Nahid, Payam, Mase, Sundari R, Migliori, Giovanni Battista, Sotgiu, Giovanni, Bothamley, Graham H, Brozek, Jan L, Cattamanchi, Adithya, Cegielski, J Peter, Chen, Lisa, Daley, Charles L, Dalton, Tracy L, Duarte, Raquel, Fregonese, Federica, Horsburgh, Jr, C Robert, Ahmad Khan, Faiz, Kheir, Fayez, Lan, Zhiyi, Lardizabal, Alfred, Lauzardo, Michael, Mangan, Joan M, Marks, Suzanne M, McKenna, Lindsay, Menzies, Dick, Mitnick, Carole D, Nilsen, Diana M, Parvez, Farah, Peloquin, Charles A, Raftery, Ann, Schaaf, H Simon, Shah, Neha S, Starke, Jeffrey R, Wilson, John W, Wortham, Jonathan M, Chorba, Terence, Seaworth, Barbara

“… The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America …”
Weitere Angaben

Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016 von Cegielski, J Peter, Chan, Pei-Chun, Lan, Zhiyi, Udwadia, Zarir F, Viiklepp, Piret, Yim, Jae-Joon, Menzies, Dick

“… As new drugs are developed for multidrug-resistant tuberculosis (MDR-TB), the role of currently used drugs must be reevaluated. We combined individual-level …”
Weitere Angaben

Extensively drug-resistant tuberculosis: "there must be some kind of way out of here" von Cegielski, J Peter

“… Over the past 7 decades, Mycobacterium tuberculosis has developed resistance to virtually every new drug used to treat tuberculosis, resulting recently in the …”
Weitere Angaben

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis von Alghamdi, Wael A, Alsultan, Abdullah, Al-Shaer, Mohammad H, An, Guohua, Ahmed, Shahriar, Alkabab, Yosra, Banu, Sayera, Barbakadze, Ketevan, Houpt, Eric, Kipiani, Maia, Mikiashvili, Lali, Schmidt, Stephan, Heysell, Scott K, Kempker, Russell R, Cegielski, J Peter, Peloquin, Charles A

“… Limited pharmacokinetic/pharmacodynamic (PK/PD) data exist on cycloserine in tuberculosis (TB) patients. We pooled several studies into a large PK data set to …”
Weitere Angaben

HIV infection and multidrug-resistant tuberculosis: the perfect storm von Wells, Charles D, Cegielski, J Peter, Nelson, Lisa J, Laserson, Kayla F, Holtz, Timothy H, Finlay, Alyssa, Castro, Kenneth G, Weyer, Karin

“… Multidrug-resistant (MDR) tuberculosis (TB) has emerged as a global epidemic, with ~425,000 new cases estimated to occur annually. The global human …”
Weitere Angaben

Molecular Evaluation of Fluoroquinolone Resistance in Serial Mycobacterium tuberculosis Isolates from Individuals Diagnosed with Multidrug-Resistant Tuberculosis von Willby, Melisa, Chopra, Paige, Lemmer, Darrin, Klein, Katherine, Dalton, Tracy L, Engelthaler, David M, Cegielski, J Peter, Posey, James E

“… Fluoroquinolones (FQ) are crucial components of multidrug-resistant tuberculosis (MDR TB) treatment. Differing levels of resistance are associated with …”
Weitere Angaben

Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion von Click, Eleanor S, Kurbatova, Ekaterina V, Alexander, Heather, Dalton, Tracy L, Chen, Michael P, Posey, James E, Ershova, Julia, Cegielski, J Peter

“… Mutations in the genes inhA, katG, and rpoB confer resistance to anti-tuberculosis (TB) drugs isoniazid and rifampin. We questioned whether specific mutations …”
Weitere Angaben

Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection von Al-Shaer, Mohammad H, Alghamdi, Wael A, Alsultan, Abdullah, An, Guohua, Ahmed, Shahriar, Alkabab, Yosra, Banu, Sayera, Barbakadze, Ketevan, Houpt, Eric, Kipiani, Maia, Mikiashvili, Lali, Cegielski, J Peter, Kempker, Russell R, Heysell, Scott K, Peloquin, Charles A

“… Fluoroquinolones are group A drugs in tuberculosis guidelines. We aim to compare the culture conversion between new-generation (levofloxacin and moxifloxacin) …”
Weitere Angaben

A University-Led Contact Tracing Program Response to a COVID-19 Outbreak Among Students in Georgia, February-March 2021 von Harrington, Kristin R V, Siira, Meron R, Rothschild, Elizabeth P, Rabinovitz, Sharon R, Shartar, Samuel, Clark, David, Isakov, Alexander, Chamberlain, Allison, Gelaye, Enku, Cegielski, J Peter, Gandhi, Neel R

“… Few reports have described how university programs have controlled COVID-19 outbreaks. Emory University established a case investigation and contact tracing …”
Weitere Angaben

Worldwide Emergence of Extensively Drug-resistant Tuberculosis von Shah, N. Sarita, Wright, Abigail, Bai, Gill-Han, Barrera, Lucia, Boulahbal, Fadila, Martín-Casabona, Nuria, Drobniewski, Francis, Gilpin, Chris, Havelková, Marta, Lepe, Rosario, Lumb, Richard, Metchock, Beverly, Portaels, Françoise, Rodrigues, Maria Filomena, Rüsch-Gerdes, Sabine, Van Deun, Armand, Vincent, Veronique, Laserson, Kayla, Wells, Charles, Cegielski, J. Peter

“… Mycobacterium tuberculosis strains that are resistant to an increasing number of second-line drugs used to treat multidrug-resistant tuberculosis (MDR TB) are …”
Volltext

Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005–2010 von Smith, Sarah E., Ershova, Julia, Vlasova, Natalia, Nikishova, Elena, Tarasova, Irina, Eliseev, Platon, Maryandyshev, Andrey O., Shemyakin, Igor G., Kurbatova, Ekaterina, Cegielski, J. Peter

“… Acquired resistance to antituberculosis drugs decreases effective treatment options and the likelihood of treatment success. We identified risk factors for …”
Volltext

Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis von Al-Shaer, Mohammad H, Märtson, Anne-Grete, Alghamdi, Wael A, Alsultan, Abdullah, An, Guohua, Ahmed, Shahriar, Alkabab, Yosra, Banu, Sayera, Houpt, Eric R, Ashkin, David, Griffith, David E, Cegielski, J Peter, Heysell, Scott K, Peloquin, Charles A

“… Ethionamide (ETA), an isonicotinic acid derivative, is part of the multidrug-resistant tuberculosis (MDR-TB) regimen. The current guidelines have deprioritized …”
Weitere Angaben

Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study von Yuen, Courtney M., Kurbatova, Ekaterina V., Tupasi, Thelma, Caoili, Janice Campos, Van Der Walt, Martie, Kvasnovsky, Charlotte, Yagui, Martin, Bayona, Jaime, Contreras, Carmen, Leimane, Vaira, Ershova, Julia, Via, Laura E., Kim, HeeJin, Akksilp, Somsak, Kazennyy, Boris Y., Volchenkov, Grigory V., Jou, Ruwen, Kliiman, Kai, Demikhova, Olga V., Vasilyeva, Irina A., Dalton, Tracy, Cegielski, J. Peter

“… For treating multidrug-resistant tuberculosis (MDR TB), the World Health Organization (WHO) recommends a regimen of at least four second-line drugs that are …”
Volltext

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia von Ershova, Julia V., Volchenkov, Grigory V., Somova, Tatiana R., Kuznetsova, Tatiana A., Kaunetis, Natalia V., Kaminski, Dorothy, Demikhova, Olga V., Chernousova, Larisa N., Vasilyeva, Irina A., Kerr, Eleanor M., Cegielski, J. Peter, Kurbatova, Ekaterina V.

“… Background The main advantage of GeneXpert MTB/RIF ® (Xpert) molecular diagnostic technology is the rapid detection of M .tuberculosis DNA and mutations …”
Volltext

Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries von Kurbatova, Ekaterina V., Dalton, Tracy, Ershova, Julia, Tupasi, Thelma, Caoili, Janice Campos, Van Der Walt, Martie, Kvasnovsky, Charlotte, Yagui, Martin, Bayona, Jaime, Contreras, Carmen, Leimane, Vaira, Via, Laura E., Kim, HeeJin, Akksilp, Somsak, Kazennyy, Boris Y., Volchenkov, Grigory V., Jou, Ruwen, Kliiman, Kai, Demikhova, Olga V., Cegielski, J. Peter

“… Data from a large multicenter observational study of patients with multidrug-resistant tuberculosis (MDR TB) were analyzed to simulate the possible use of 2 …”
Volltext

Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa von Kvasnovsky, Charlotte L., Cegielski, J. Peter, van der Walt, Martie L.

“… We analyzed data for a retrospective cohort of patients treated for extensively drug-resistant tuberculosis in 2 provinces in South Africa and compared …”
Volltext

Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients von Kvasnovsky, Charlotte L, Cegielski, J Peter, Erasmus, Roshen, Siwisa, N Olga, Thomas, Khulile, der Walt, Martie L van

“… Tuberculosis is a leading cause of morbidity and mortality worldwide. Patients with extensively drug-resistant tuberculosis (XDR-TB) have had high mortality …”
Weitere Angaben

Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia von Ershova, Julia V., Volchenkov, Grigory V., Kaminski, Dorothy A., Somova, Tatiana R., Kuznetsova, Tatiana A., Kaunetis, Natalia V., Cegielski, J. Peter, Kurbatova, Ekaterina V.

“… We studied the epidemiology of drug-resistant tuberculosis (TB) in Vladimir Region, Russia, in 2012. Most cases of multidrug-resistant TB (MDR TB) were caused …”
Volltext

Multidrug-resistant Tuberculosis Management in Resource-limited Settings von Nathanson, Eva, Lambregts-van Weezenbeek, Catharina, Rich, Michael L., Gupta, Rajesh, Bayona, Jaime, Blondal, Kai, Caminero, Jose A., Cegielski, J. Peter, Danilovits, Manfred, Espinal, Marcos A., Hollo, Vahur, Jaramillo, Ernesto, Leimane, Vaira, Mitnick, Carole D., Mukherjee, Joia S., Nunn, Paul, Pasechnikov, Alexander, Tupasi, Thelma, Wells, Charles, Raviglione, Mario C.

“… Evidence of successful management of multidrug-resistant tuberculosis (MDRTB) is mainly generated from referral hospitals in high-income countries. We evaluate …”
Volltext

Factors associated with poor treatment outcomes among tuberculosis patients in Kyangwali Refugee Settlement, Uganda, 2016–2017 von Nguna, Joyce, Okethwangu, Denis, Kabwama, Steven Ndugwa, Aliddeki, Dativa Maria, Kironde, Susan Kizito, Birungi, Doreen, Eurien, Daniel, Ario, Alex Riolexus, Lukoye, Deus, Kasozi, Julius, Cegielski, Peter J.

“… Communicable diseases, alone or in combination with malnutrition, account for most deaths in complex emergencies including refugee settings. Tuberculosis and …”
Volltext